2024 perioperative management glp-1 receptor agonists anesthesia of patients on agonists: Risks, recommendations, and future directions—A narrative review Perioperative Considerations for Patients on

Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021

Learn what research shows about GLP-1 medications for autoimmune thyroid conditions, safety considerations, and evidence-based treatment options for Hashimoto's thyroiditis.

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data

Obesity and associated metabolic disorders such as type 2 diabetes mellitus and polycystic ovary syndrome are rising globally, contributing to infertility and adverse pregnancy outcomes